Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Trading Indicators Flashing Green

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson Dec 17, 2022 11:38am

329 Views

Post# 35177604

Trading Indicators Flashing Green

While we wait for the news are all green now:

https://swingtradebot.com/equities/ONCY

I think we can finally break and stay the 2$ USD mark for good, making this stock marginable again for the US market.

I think we close near or above 3$ by year end.
We will trade near 5$ by end of Jan 2023.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023